At the recent Crittenden Medical Insurance Conference held virtually from April 13-14, 2021, Michael Wong, JD (Founder and Executive Director, Physician-Patient Alliance for Health & Safety (PPAHS)) predicted that malpractice cases will likely rise post-COVID due to delayed diagnosis.
Presenting with Mr. Wong were:
- Naresh M. Punjabi, MD, PhD (Mary Jane and Lino Sertel Professor of Pulmonary Diseases, Department of Medicine, University of Miami, Miller School of Medicine)
- Jason P. Kirkness, Ph.D. (Medicine), ATSF (Drug/Device Discovery and Development Committee, American Thoracic Society; VP Medical and Clinical Affairs, 4DMedical)
Need for Safer Lung Function Testing
New survey finds that fears of COVID-19 are the overwhelming reason for not conducting lung function tests during the pandemic.
Respondents to the survey (50%) would like a safer way to test lung function is needed, such as a non-aerosol procedure (28%) and software that would provide an analysis of lung function (20%).
New Technological Solutions
Both the spirometer and plethysmography are technologies that were developed in the 19th century. We searched the internet to identify new technological solutions to determine lung function testing.
Please click on the video below from 4DMedical about their XV Technology and how it delivers regional, functional lung imaging using existing hospital hardware.
After you’ve watched the video, please tell us what you think and if you know of new technological solutions for testing lung function.
The Physician-Patient Alliance for Health and Safety (PPAHS) today announced the launch of a new initiative to help Chronic Obstructive Pulmonary Disease (COPD) patients during COVID-19, empowering them to better understand their conditions and to not delay seeking medical attention. The Virtual Patient Care initiative is supported by grants from GlaxoSmithKline and 4DMedical.
By Michael Wong, JD (Executive Director, Physician-Patient Alliance for Health & Safety)
Patients with chronic obstructive pulmonary disease (COPD) and other respiratory illnesses are more at risk of getting COVID-19. Lung function tests, such as spirometry and plethysmography, are often used to determine how well the lungs are working. These tests measure lung volume, capacity, rates of flow, and gas exchange. Information from these tests is helpful to clinicians to diagnose and determine the appropriate treatment for patients suffering from lung disorders.
Lung function testing is used to measure how well your lungs are working.
Editor’s Note: In this article, Michael Wong, JD (Founder/Executive Director, Physician-Patient Alliance for Health & Safety) with Arielle Bernstein Pinsof, MPP, Finn Partners and Gil Bashe, Managing Partner, Finn Partners Health Practice take the position that decreasing the opioid epidemic begins in the doctor’s office and healthcare facilities.
By Michael Wong, JD (Founder/Executive Director, Physician-Patient Alliance for Health & Safety) with Arielle Bernstein Pinsof, MPP, Finn Partners and Gil Bashe, Managing Partner, Finn Partners Health Practice
The tragedy of our national opioid epidemic has gripped hearts and headlines for months now with heartbreaking personal stories, images and statistics. But the truth is, not all overdose deaths are taking place on the streets — so while physicians and lawmakers race to find interventions that work on the front lines in our communities, shouldn’t we also take concrete steps to reduce opioid overdoses in the clinical setting — where they are highly preventable — where the full range of interventions are at hand?
Editor’s Note: This editorial from the desk of PPAHS’s Executive Director asks whether the debate over the 1-hour sepsis bundle should focus on improving care and not on making sure certain procedures are done within a 60-minute timeframe.
By Michael Wong, JD (Founder and Executive Director, Physician-Patient Alliance for Health & Safety)
The recent kerfuffle over the 1-Hour Sepsis Bundle has missed the point about the need for better patient care and a much needed effort to save patient lives.
In 2002, the European Society of Intensive Care Medicine, the Society of Critical Care Medicine, and the International Sepsis Forum came together and formed the Surviving Sepsis Campaign aiming to reduce sepsis-related mortality by 25% within 5 years. The goals of the Surviving Sepsis Campaign were to improve the management of sepsis through a 7-point agenda including:
- Building awareness of sepsis
- Improving diagnosis
- Increasing the use of appropriate treatment
- Educating healthcare professionals
- Improving post-ICU care
- Developing guidelines of care
- Implementing a performance improvement program
The Physician-Patient Alliance for Health & Safety wishes you a safe and Happy New Year!
To help make 2019 patient safe, please implement the following 3 recommendations to keep your patients safe:
Patients Receiving Opioids Must Be Monitored With Continuous Electronic Monitoring
Much of the public attention has been focused on the harm caused by prescription use and abuse of opioids. However, there is another facet that must be focused on: opioid-induced respiratory depression in clinical settings. This includes patients undergoing moderate and conscious sedation, or recovering from procedures and managing pain using a patient-controlled analgesia (PCA) pump, particularly those during the postoperative period.
In this article published in the December 2018 issue of the British Columbia Medical Journal, Drs Richard Merchant and Matt Kurrek encourage the use of capnographic monitoring to improve the safety of patients undergoing procedural sedation.
By Richard Merchant, MD, FRCPC (Clinical Professor, University of British Columbia, Department of Anesthesia, Pharmacology, & Therapeutics) explained in a clinical education podcast with Matt Kurrek, MD, FRCPC (Professor, Department of Anesthesia, University of Toronto)
By Jeffrey S. Vender, MD
Clinicians and even the general public are aware of the dangers of sepsis, the life-threatening illness caused by a body’s response to an infection. Irrespective of one’s perception of pharmaceutical marketing materials or the evidence-based medicine used, awareness about sepsis has led to earlier diagnosis and interventions that have likely saved countless patients’ lives.
Moreover, hospitalists have played a key role in sepsis prevention.
Please click here to read the article by Dr. Vender.
Dr. Jeffery Vender is the emeritus Harris Family Foundation chairman of the department of anesthesiology at NorthShore University Health System in Evanston, Ill. He is clinical professor at the University of Chicago Pritzker School of Medicine and chairman, Clinical Advisory Committee, Respiratory Compromise Institute. Dr. Vender has consulted with Medtronic